Forty years of human G-CSF: A short history in time

被引:2
作者
Welte, Karl [1 ]
机构
[1] Univ Childrens Hosp, Tubingen, Germany
关键词
G-CSF; recombinant G-CSF; Filgrastim; Lenograstim; congenital neutropenia; chemotherapy induced neutropenia; COLONY-STIMULATING FACTOR; CELLS; NEUTROPENIA; PURIFICATION;
D O I
10.1111/bjh.19713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human G-CSF was identified in 1984 at Memorial Sloan-Kettering Cancer Centre, New York. Based on these findings, recombinant G-CSF was developed by Amgen, Thousand Oaks. In 1987, clinical trials began using recombinant G-CSF in cancer patients following chemotherapy to reduce the duration of neutropenia and in patients with congenital neutropenia (CN) to increase the number of neutrophils. It has changed the quality of life for many cancer patients and saved the lives of many patients with (CN).
引用
收藏
页码:1296 / 1298
页数:3
相关论文
共 50 条
  • [21] DRUG ERUPTION CAUSED BY RECOMBINANT HUMAN G-CSF
    SASAKI, O
    YOKOYAMA, A
    UEMURA, S
    FUJINO, S
    INOUE, Y
    KOHNO, N
    HIWADA, K
    INTERNAL MEDICINE, 1994, 33 (10) : 641 - 643
  • [22] A role for G-CSF and GM-CSF in nonmyeloid cancers
    Aliper, Alexander M.
    Frieden-Korovkina, Victoria P.
    Buzdin, Anton
    Roumiantsev, Sergey A.
    Zhavoronkov, Alex
    CANCER MEDICINE, 2014, 3 (04): : 737 - 746
  • [23] Development of a new G-CSF product based on biosimilarity assessment
    Gascon, P.
    Fuhr, U.
    Soergel, F.
    Kinzig-Schippers, M.
    Makhson, A.
    Balser, S.
    Einmahl, S.
    Muenzberg, M.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1419 - 1429
  • [24] Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022
    Kimura, Shoji
    Shigeta, Keisuke
    Tamura, Shingo
    Uchino, Keita
    Kimura, Takahiro
    Ozaki, Yukinori
    Nishio, Hiroshi
    Tsuchihashi, Kenji
    Ichihara, Eiki
    Endo, Makoto
    Yano, Shingo
    Maruyama, Dai
    Yoshinami, Tetsuhiro
    Susumu, Nobuyuki
    Takekuma, Munetaka
    Motohashi, Takashi
    Ito, Mamoru
    Baba, Eishi
    Ochi, Nobuaki
    Kubo, Toshio
    Kamiyama, Yutaro
    Nakao, Shinji
    Tamura, Shinobu
    Nishimoto, Hitomi
    Kato, Yasuhisa
    Sato, Atsushi
    Takano, Toshimi
    Miura, Yuji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (05) : 559 - 563
  • [25] Optimal use of G-CSF administration after hematopoietic SCT
    Trivedi, M.
    Martinez, S.
    Corringham, S.
    Medley, K.
    Ball, E. D.
    BONE MARROW TRANSPLANTATION, 2009, 43 (12) : 895 - 908
  • [26] Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022
    Shoji Kimura
    Keisuke Shigeta
    Shingo Tamura
    Keita Uchino
    Takahiro Kimura
    Yukinori Ozaki
    Hiroshi Nishio
    Kenji Tsuchihashi
    Eiki Ichihara
    Makoto Endo
    Shingo Yano
    Dai Maruyama
    Tetsuhiro Yoshinami
    Nobuyuki Susumu
    Munetaka Takekuma
    Takashi Motohashi
    Mamoru Ito
    Eishi Baba
    Nobuaki Ochi
    Toshio Kubo
    Yutaro Kamiyama
    Shinji Nakao
    Shinobu Tamura
    Hitomi Nishimoto
    Yasuhisa Kato
    Atsushi Sato
    Toshimi Takano
    Yuji Miura
    International Journal of Clinical Oncology, 2024, 29 : 559 - 563
  • [27] Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
    Bakherad, Hamid
    Setayesh, Neda
    Gargari, Seyed Latif Mousavi
    Ebrahimizadeh, Walead
    Mavandadnejad, Faranak
    Faghfuri, Elnaz
    Ebrahimi, Soheila
    Heiat, Mohammad
    Shahpari, Mona
    Sepehrizadeh, Zargham
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2020, 15 (04) : 381 - 389
  • [28] Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF
    Siena, S
    Bregni, M
    Gianni, AM
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) : 27 - 39
  • [29] HUMAN G-CSF PRODUCED BY ADHERENT CELLS IN THE PRESENCE OF HUMAN RECOMBINANT GM-CSF
    HARA, H
    OKADA, Y
    KOHRIYA, T
    NAMIKI, M
    MISAWA, M
    OHE, Y
    KAI, S
    ANDO, S
    KOBABA, R
    KOHSAKI, M
    YAMAMOTO, Y
    FURUYAMA, J
    INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 (05): : 357 - 367
  • [30] G-CSF IN RADIOTHERAPY-INDUCED NEUTROPENIA
    BURRAI, I
    IACOANGELI, M
    PETTI, R
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1993, 12 (04) : 265 - 268